Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Bill and Melinda Gates Foundation comes out in support of ‘limited’ vaccine waiver

‘This will not be an immediate fix,’ say billionaires after US answers calls from developing countries

Gino Spocchia
Friday 07 May 2021 16:27 BST
Comments
Bill Gates says vaccine formulas shouldn't be shared with developing world
Leer en Español

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The Bill and Melinda Gates Foundation has said it supports a limited waiver of patents for the production of Covid vaccines, following a surprise announcement from US officials earlier in the week.

In a statement on Friday, Mr and Ms Gates said their philanthropic foundation was in support of a “narrow” waiver for vaccines produced in the US — and around the world, via the WTO.

“No barriers should stand in the way of equitable access to vaccines, including intellectual property, which is why we are supportive of a narrow waiver during the pandemic,” wrote the Gateses. “ This will not be an immediate fix, but it is important to prepare for future outbreaks.”

It followed an announcement from the Biden administration on Wednesday saying for the first time it was in support of a temporary waiver for patents and intellectual property rights for Covid vaccines.

If approved by the World Trade Organisation (WTO), it would — in theory — allow vaccines to be produced by developing countries currently suffering from severe outbreaks of Covid.

The remarks from Mr Gates follow recent concerns from the billionaire philanthropist and Microsoft founder of waiving intellectual rights for vaccines.

"There's only so many vaccine factories in the world and people are very serious about the safety of vaccines," Mr Gates told Sky News a fortnight ago — amid warnings that a waiver is not a fix-all solution for current shortages in supply.

"The thing that's holding things back in this case is not intellectual property. There's not, like, some idle vaccine factory with regulatory approval that makes magically safe vaccines,” said Mr Gates. “You've got to do the trials”.

On Friday, the Microsoft founder went on to say that the Gates Foundation would continue calling for COVAX — a World Health Organisation (WHO) initiative to supply developing countries with vaccines — “to be fully funded.”

The Gates Foundation remains one of the biggest donors of Covid research and support for developing countries, with $300m (£215m) committed to vaccine research, production and testing, so far.

Countries including South Africa and India, who in recent weeks experienced exponential increases in cases of Covid, were among the first to call on the US and others to share the intellectual property rights for Covid vaccines in October.

The Biden administration’s announcement of waivers increases the pressure on the UK and EU to also support the WTO proposals.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in